Basic Information
Aerami Therapeutics is developing novel inhaled therapies for severe respiratory and chronic diseases. Our platform aims to overcome the limitations of injectable, oral, and other inhaled formulation technologies in managing severe respiratory and chronic conditions. Ultimately, our goal is to enhance treatment efficacy and improve patient lives.
Aerami Therapeutics, Inc.
NorthCarolina,United States of America
15~50 people
January 01, 2010
info@aerami.com
